97354 ⎘
Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
Fusion protein that directs vaccine antigens to antigen-presenting cells, and applications thereof
#902HUMAN SERUM ALBUMIN LINKERS AND CONJUGATES THEREOF
#903CADHERIN-11 ANTAGONISTS AND METHODS FOR THE TREATMENT OF INFLAMMATORY JOINT DISORDERS
#904High affinity NY-ESO T cell receptor
#905Fusion Proteins of Mannose Binding Lectins for Treatment of Disease
#906High affinity NY-ESO T cell receptors
#907Cadherin-11 EC1 domain antagonists for treating inflammatory joint disorders
#908Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody
#909Ii-KEY HYBRID PEPTIDES THAT MODULATE THE IMMUNE RESPONSE TO INFLUENZA
#910COMPOSITIONS OF TOLL-LIKE RECEPTOR AGONISTS AND PAPILLOMAVIRUS ANTIGENS AND METHODS OF USE THEREOF
#911Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity
#912Synthetic apolipoprotein E mimicking polypeptides and methods of use
#913Fusion molecules and IL-15 variants
#914Complexation of fatty acid-conjugated molecules with albumin
#915Modified bacteriocins and methods for their use
#916Method of treating a cutaneous wound using a coiled coil chimeric molecule
#917Peptides and related molecules that bind to TALL-1
#918VECTOR ENCODING THERAPEUTIC POLYPEPTIDE AND SAFETY ELEMENTS TO CLEAR TRANSDUCED CELLS
#919Novel Class of Monospecific and Bispecific Humanized Antibodies that Target the Insulin-like Growth Factor Type I Receptor (IGF-1R)
#920BISPECIFIC MOLECULE BINDING TLR9 AND CD32 AND COMPRISING A T CELL EPITOPE FOR TREATMENT OF ALLERGIES
#921Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR
#922MULTIMERIC Fc RECEPTOR POLYPEPTIDES INCLUDING A MODIFIED Fc DOMAIN
#923Polypeptides that bind Trail-R1 and Trail-R2
#924Ligand Targeted Nanocapsules for the delivery of RNAi and other Agents
#925COMPOSITIONS AND METHODS FOR BLOOD-BRAIN BARRIER DELIVERY IN THE MOUSE
#926Cytokine-based fusion proteins for treatment of multiple sclerosis
#927COMPOSITIONS AND METHODS FOR TARGETING A POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM
#928CHIMERIC VACCINE ANTIGENS AGAINST THE AVIAN INFLUENZA VIRUS
#929Chimeric viral envelopes
#930Fusion molecules and IL-15 variants
#931B7-H1 Antibodies
#932Chimeric vaccine antigens against classical swine fever virus
#933Multivalent fibronectin based scaffold domain proteins
#934Methods and compositions for needleless delivery of macromolecules
#935B7-H1, a novel immunoregulatory molecule
#936Constructs for delivery of therapeutic agents to neuronal cells
#937Lytic domain fusion constructs and methods of making and using same
#938Cadherin-11 antagonists and methods for the treatment of inflammatory joint disorders
#939Lytic domain fusion constructs and methods of making and using same
#940LYTIC DOMAIN FUSION CONSTRUCTS AND METHODS OF MAKING AND USING SAME
#941Engineered fusion molecules immunotherapy in cancer and inflammatory diseases
#942TARGETED THERAPEUTIC PROTEINS
#943Methods and compositions for generating bioactive assemblies of increased complexity and uses
#944Tolerizing agents
#945NON-VIRAL GENE DELIVERY COMPLEX
#946Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#947LOW DENSITY LIPOPROTEIN RECEPTOR-MEDIATED siRNA DELIVERY
#948Method and agent for immobilizing protein via protein bound to silicon oxide-containing substance
#949Combination of an anti-ED—B fibronectin domain antibody—IL-2 fusion protein and gemcitabine
#950Nogo receptor antagonists
#951Methods for attenuating virus strains for diagnostic and therapeutic uses
#952Methods and compositions for the treatment and prevention of cancer
#953Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#954COMPOUNDS AND PEPTIDES THAT BIND THE KGF RECEPTOR
#955G-CSF transferrin fusion proteins
#956Method for targeting lysosomal enzymes
#957OLIGOMERIC RECEPTOR LIGAND PAIR MEMBER COMPLEXES
#958Chimeric proteins, their preparation and pharmaceutical compositions containing them
#959Method for Producing Epidermal Growth Factor Using Fusion Proteins Comprising Fas-1 Domain
#960Non-human organism comprising a gene expression modulation system encoding a chimeric retinoid X receptor
#961Methods and compositions for targeting proteins across the blood brain barrier
#962Antibody-avidin fusion proteins as cytotoxic drugs
#963Method of treating a muscle-related condition with modified IGF1 polypeptides
#964Method of modulating gene expression using an ecdysone receptor-based inducible gene expression system
#965Virus-like particles for the induction of autoantibodies
#966Modified bacteriocins and methods for their use
#967Method of delivering RNA interference and uses thereof
#968Compositions and methods for identifying antigens which elicit an immune response
#969Modified bacteriocins and methods for their use
#970SHIELDED ADENOVIRAL VECTORS AND METHODS OF USE
#971Binding Agents
#972Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody
#973Multimeric Fc receptor polypeptides
#974GRP78 targeting peptides and methods employing same
#975Methods of using chimeric coiled coil molecule to treat ischemic disease
#976Modular molecular clasps and uses thereof
#977Adenoviral expression vector comprising a CD40L fusion protein adapted to elicit cellular immunity
#978Targeting of Herpes simplex virus to specific receptors
#979Therapeutic Systems
#980Targeting proteins to deliver therapeutic or diagnostic reagents
#981Optimization of immunomodulatory properties of genetic vaccines
#982Optimization of immunomodulatory properties of genetic vaccines
#983Methods and compositions for generating bioactive assemblies of increased complexity and uses
#984Modified transferin-antibody fusion proteins
#985Expression and secretion of icIL-1 receptor antagonist type II
#986Hetero type pentamer recombinant vaccine
#987Virus-like particles for the induction of autoantibodies
#988Compositions and methods for targeting a polypeptide to the central nervous system
#989Methods and compositions for needleless delivery of macromolecules
#990Cancer treatment kits using antibodies to aminophospholipids
#991Peptides and related molecules that bind to TALL-1
#992Methods and compositions for targeting proteins across the blood brain barrier
#993Antigen library immunization
#994Modified IGF1 polypeptides with increased stability and potency
#995Superior molecular vaccine based on self-replicating RNA, suicidal DNA or naked DNA vector, that links antigen with polypeptide that promotes antigen presentation
#996Optimization of immunomodulatory properties of genetic vaccines
#997Compositions and methods of use of targeting peptides for diagnosis and therapy
#998Optimization of immunomodulatory properties of genetic vaccines
#999Human immunodeficiency virus gp41 mimetibody polypeptides
#1000Anticoagulant fusion protein anchored to cell membrane
#1001Compositions and methods for targeting a polypeptide to the central nervous system
#1002Oligomeric receptor ligand pair member complexes
#1003Optimization of immunomodulatory properties of genetic vaccines
#1004Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins
#1005Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof
#1006Fusion molecules and IL-15 variants
#1007Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
#1008Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene